BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34521440)

  • 1. Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression.
    Jiang Z; Zhang Y; Zhang Y; Jia Z; Zhang Z; Yang J
    Cell Commun Signal; 2021 Sep; 19(1):93. PubMed ID: 34521440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression.
    Lin F; Yin HB; Li XY; Zhu GM; He WY; Gou X
    Int J Oncol; 2020 Jan; 56(1):151-164. PubMed ID: 31814034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
    Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
    Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
    Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
    Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
    Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
    Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
    Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
    Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression.
    Chen WX; Wang DD; Zhu B; Zhu YZ; Zheng L; Feng ZQ; Qin XH
    Aging (Albany NY); 2021 Mar; 13(7):10415-10430. PubMed ID: 33752173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
    Jin J; Yu G
    World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
    Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
    Front Immunol; 2018; 9():871. PubMed ID: 29867925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes-mediated phenotypic switch of macrophages in the immune microenvironment after spinal cord injury.
    Peng P; Yu H; Xing C; Tao B; Li C; Huang J; Ning G; Zhang B; Feng S
    Biomed Pharmacother; 2021 Dec; 144():112311. PubMed ID: 34653754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.
    Shen T; Miao S; Zhou Y; Yi X; Xue S; Du B; Tang C; Qu L; Fu D; Jia R; He H
    Cell Commun Signal; 2022 Sep; 20(1):152. PubMed ID: 36153596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [M2 macrophage-derived exosomal lncRNA NR_028113.1 promotes macrophage polarization possibly by activating the JAK2/STAT3 signaling pathway].
    Zhang M; Li Z; Pei W; Li X; Yang H; Zhu X; Lü K
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):393-399. PubMed ID: 37087583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
    Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
    Wang X; Lyu J; Ji A; Zhang Q; Liao G
    Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
    Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
    Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.
    Moradi-Chaleshtori M; Bandehpour M; Soudi S; Mohammadi-Yeganeh S; Hashemi SM
    Cancer Immunol Immunother; 2021 May; 70(5):1323-1339. PubMed ID: 33140190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.